An effective vaccine rolled over the course of 2021-22 would probably result in weaker demand for COVID-19 related products and some consumer goods, removing a tailwind to exporters in parts of Asia and Central & Eastern Europe. Meanwhile, higher commodity prices would lift export values for natural resources exporters. And a recovery in tourism would be a welcome boost to services exports from the likes of Thailand and Turkey.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services